Characterization of ovarian cancer long-term responders on olaparib.
Stephanie Lheureux
No relevant relationships to disclose
Jonathan A. Ledermann
Honoraria - AstraZeneca
Stanley B. Kaye
Consultant or Advisory Role - AstraZeneca
Charlie Gourley
Consultant or Advisory Role - AstraZeneca; Boehringer Ingelheim; Chugai Pharma; GlaxoSmithKline; MSD; Roche
Honoraria - Boehringer Ingelheim; Chugai Pharma; MSD; Roche
Research Funding - AstraZeneca; GlaxoSmithKline; Roche
Other Remuneration - Boehringer Ingelheim; PharmaMar; Roche
Michael Friedlander
No relevant relationships to disclose
David Bowtell
Consultant or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
Jacques De Greve
No relevant relationships to disclose
Anna deFazio
Consultant or Advisory Role - AstraZeneca
Honoraria - Roche
Research Funding - AstraZeneca
Ronnie Shapira-Frommer
No relevant relationships to disclose
Johann Sebastian De Bono
No relevant relationships to disclose
M. William Audeh
No relevant relationships to disclose
Elise C. Kohn
No relevant relationships to disclose
Kathryn Alsop
Consultant or Advisory Role - AstraZeneca
Research Funding - AstraZeneca
Clare L. Scott
No relevant relationships to disclose
Ursula Matulonis
No relevant relationships to disclose
Bella Kaufman
No relevant relationships to disclose
Brent Burger
Employment or Leadership Position - AstraZeneca
Jane D Robertson
Employment or Leadership Position - AstraZeneca
Tony Ho
Employment or Leadership Position - AstraZeneca
Amit M. Oza
No relevant relationships to disclose